253 related articles for article (PubMed ID: 11795020)
1. [Rhabdomyolysis and anuric kidney failure induced by the treatment with a gemfibrozil-cerivastatin combination].
Sirvent AE; Cabezuelo JB; Enríquez R; Amorós F; González C; Reyes A
Nefrologia; 2001; 21(5):497-500. PubMed ID: 11795020
[TBL] [Abstract][Full Text] [Related]
2. [Rhabdomyolysis, acute renal failure and use of cerivastatin combined with gemfibrozil. New evidence].
SantaCruz PL; González A; León ME; Fernández MY
Nefrologia; 2002; 22(3):301-2. PubMed ID: 12123135
[No Abstract] [Full Text] [Related]
3. A case with severe rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy--a case report.
Ozdemir O; Boran M; Gökçe V; Uzun Y; Koçak B; Korkmaz S
Angiology; 2000 Aug; 51(8):695-7. PubMed ID: 10959522
[TBL] [Abstract][Full Text] [Related]
4. [Myopathy with rhabdomyolysis as an adverse effect of simultaneous treatment with cerivastatin and gemfibrozil].
Huić M; Anić B; Cikes N; Bosnić D; Sentić M; Markeljević J; Mayer M; Pazanin L
Lijec Vjesn; 2002; 124(3-4):73-6. PubMed ID: 18956824
[TBL] [Abstract][Full Text] [Related]
5. Rhabdomyolysis associated with cerivastatin plus gemfibrozil combined regimen.
Marsà Carretero M; Alos Manrique C; Valles Callol JA
Br J Gen Pract; 2002 Mar; 52(476):235-6. PubMed ID: 12030671
[No Abstract] [Full Text] [Related]
6. Rhabdomyolysis from the combination of a statin and gemfibrozil: an uncommon but serious adverse reaction.
Kind AH; Zakowski LJ; McBride PE
WMJ; 2002; 101(7):53-6. PubMed ID: 12426921
[TBL] [Abstract][Full Text] [Related]
7. Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy.
Chang JT; Staffa JA; Parks M; Green L
Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):417-26. PubMed ID: 15269925
[TBL] [Abstract][Full Text] [Related]
8. [Withdrawal of cerivastatin revealed a flaw of post-marketing surveillance system in the United States].
Saito M; Hirata-Koizumi M; Miyake S; Hasegawa R
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2005; (123):41-5. PubMed ID: 16541751
[TBL] [Abstract][Full Text] [Related]
9. Bayer pulls cerivastatin (Baycol) from market.
Wooltorton E
CMAJ; 2001 Sep; 165(5):632. PubMed ID: 11563216
[No Abstract] [Full Text] [Related]
10. Gemfibrozil greatly increases plasma concentrations of cerivastatin.
Backman JT; Kyrklund C; Neuvonen M; Neuvonen PJ
Clin Pharmacol Ther; 2002 Dec; 72(6):685-91. PubMed ID: 12496749
[TBL] [Abstract][Full Text] [Related]
11. Rhabdomyolysis associated with the combined use of hydroxymethylglutaryl-coenzyme A reductase inhibitors with gemfibrozil and macrolide antibiotics.
Landesman KA; Stozek M; Freeman NJ
Conn Med; 1999 Aug; 63(8):455-7. PubMed ID: 10500341
[TBL] [Abstract][Full Text] [Related]
12. Dual hepatic metabolism of cerivastatin--clarifications.
Guyton JR; Dujovne CA; Illingworth DR
Am J Cardiol; 1999 Aug; 84(4):497. PubMed ID: 10468102
[No Abstract] [Full Text] [Related]
13. Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin.
Jones PH; Davidson MH
Am J Cardiol; 2005 Jan; 95(1):120-2. PubMed ID: 15619408
[TBL] [Abstract][Full Text] [Related]
14. Rhabdomyolysis and renal failure associated with gemfibrozil monotherapy.
Layne RD; Sehbai AS; Stark LJ
Ann Pharmacother; 2004 Feb; 38(2):232-4. PubMed ID: 14742756
[TBL] [Abstract][Full Text] [Related]
15. Rhabdomyolysis and acute renal failure following a switchover of therapy between two fibric acid derivatives.
Kamaliah MD; Sanjay LD
Singapore Med J; 2001 Aug; 42(8):368-72. PubMed ID: 11764054
[TBL] [Abstract][Full Text] [Related]
16. Cerivastatin and gemfibrozil-associated rhabdomyolysis.
Bruno-Joyce J; Dugas JM; MacCausland OE
Ann Pharmacother; 2001 Sep; 35(9):1016-9. PubMed ID: 11573847
[TBL] [Abstract][Full Text] [Related]
17. Fatal rhabdomyolysis caused by lipid-lowering therapy.
Federman DG; Hussain F; Walters AB
South Med J; 2001 Oct; 94(10):1023-6. PubMed ID: 11702815
[TBL] [Abstract][Full Text] [Related]
18. Severe rhabdomyolysis associated with the cerivastin-gemfibrozil combination therapy: report of a case.
Lau TK; Leachman DR; Lufschanowski R
Tex Heart Inst J; 2001; 28(2):142-5. PubMed ID: 11453128
[TBL] [Abstract][Full Text] [Related]
19. Gemfibrozil-induced myositis in a patient with normal renal function.
Hahn M; Sriharan K; McFarland MS
Ann Pharmacother; 2010 Jan; 44(1):211-4. PubMed ID: 19934390
[TBL] [Abstract][Full Text] [Related]
20. [Antilipemic therapy and rhabdomyolysis].
Paragh G; Balogh Z; Romics L
Orv Hetil; 2003 Mar; 144(11):515-20. PubMed ID: 12731338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
